I am a
Home I AM A Search Login

Papers of the Week


Ther Adv Chronic Dis


Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.


Intravenous immunoglobulin (IVIG) was reported to be the third most used monotherapy in livedoid vasculopathy (LV). There is currently a lack of randomized controlled clinical trials and no standardized therapeutic regimen for IVIG therapy in LV.